Ruberti G, Gaur A, Fathman C G, Livingstone A M
Department of Medicine, Stanford University School of Medicine, California 94305.
J Exp Med. 1991 Jul 1;174(1):83-92. doi: 10.1084/jem.174.1.83.
T cell clones recognizing the sperm whale myoglobin (SpWMb) epitope 110-121 in association with H-2d major histocompatibility complex class II molecules display a very limited heterogeneity of T cell receptor (TCR) V beta usage in DBA/2 mice. All clones previously tested used the same V beta 8.2 gene segment and very restricted junctional regions. To investigate the significance of this observation in vivo, we immunized DBA/2 mice with the intact SpW Mb protein or peptide 110-121. Only the V beta 8+ T cells showed any significant response to the 110-121 epitope. The response to peptide 110-121 was then analyzed in mice which, either as a consequence of antibody depletion or through genetic deletion of TCR V beta genes, lacked V beta 8+ peripheral T cells. DBA/2 mice depleted of V beta 8+ T cells by antibody treatment responded poorly to the 110-121 peptide, and only at high antigen concentrations. In contrast, DBA/2V beta a mice (homozygous for a deletion of multiple V beta gene segments including the V beta 8 family) made a response at least as great as that made by DBA/2 mice, even though the DBA/2V beta a mice had a very restricted TCR V beta repertoire compared with DBA/2 mice. Mechanisms which might determine differences in the 110-121 specific response of DBA/2, DBA/2V beta a and F23.1-treated DBA/2 mice are discussed.
在DBA/2小鼠中,识别与H-2d主要组织相容性复合体II类分子相关的抹香鲸肌红蛋白(SpWMb)表位110-121的T细胞克隆显示出T细胞受体(TCR)Vβ使用的异质性非常有限。所有先前测试的克隆都使用相同的Vβ8.2基因片段和非常受限的连接区。为了研究这一观察结果在体内的意义,我们用完整的SpW Mb蛋白或肽110-121免疫DBA/2小鼠。只有Vβ8+ T细胞对110-121表位有任何显著反应。然后在由于抗体清除或通过TCR Vβ基因的基因缺失而缺乏Vβ8+外周T细胞的小鼠中分析对肽110-121的反应。通过抗体处理清除Vβ8+ T细胞的DBA/2小鼠对110-121肽反应不佳,且仅在高抗原浓度下有反应。相比之下,DBA/2Vβa小鼠(多个Vβ基因片段缺失包括Vβ8家族的纯合子)产生的反应至少与DBA/2小鼠一样大,尽管与DBA/2小鼠相比,DBA/2Vβa小鼠的TCR Vβ库非常受限。讨论了可能决定DBA/2、DBA/2Vβa和F23.1处理的DBA/2小鼠在110-121特异性反应中差异的机制。